Published On : July 2017 Pages : 95 Category: Medical Devices Report Code : HC07183
Industry Trend Analysis
Insulin patch pump market is expected to experience significant growth in coming years between 2022 and 2027. The market is primarily driven by rising incidence of diabetes worldwide. Diabetes is on the rise globally with a steady increase around the world especially in the world’s middle-income countries. According to World Health Organization’s Global Report on Diabetes published in 2017, the global prevalence of diabetes has nearly doubled between 1980 and 2017, rising from 4.7% to 8.5% of the adult population. In terms of number of patients, the prevalence increased from 108 million in 1980 to 422 million cases in 2017. With increasing awareness among diabetics about technologically advanced devices for treating diabetes, the market for insulin patch pumps is expected to witness favorable growth during the forecast period. However, the complexity of such devices can sometimes prevent people from readily adopting them thus restraining the market growth.
Insulin Type Outlook and Trend Analysis
Basal insulin is an insulin type which helps to stabilize blood sugar levels during periods of fasting such as during sleep or between meals. During such period, the body releases sugar (glucose) into the bloodstream which energizes the body’s cells. Basal insulin keeps a check on the levels of such glucose. Bolus insulin refers to the short acting insulin in order to balance the carbohydrate intake with meals. Basal-bolus therapy usually involves ordering multiple daily intake of insulin to replicate the natural production of insulin in the human body.
Regional Outlook and Trend Analysis
North America held a significant share of the insulin patch pump market in 2017 due to the availability of FDA approved insulin patch pumps such as the OmniPod Insulin Management System manufactured by Insulet Corporation and V-GO disposable insulin delivery device manufactured by Valeritas, Inc. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of advanced therapies for diabetes management but can experience favorable growth in coming years owing to increasing awareness related to diabetes management in the region.
Competitive Outlook and Trend Analysis
The key players operating in the global insulin patch pump market emphasize on product development in order to introduce improved diabetes management systems and capture a larger share of the market. Some of the major players in this market are, Insulet Corporation, Valeritas Holdings, Inc., CeQur SA, Cellnovo Limited, Debiotech S.A., EOFLOW CO.,LTD., Unilife Corporation and Becton, Dickinson and Company.
Insulin Patch Pump Market Segmentation:
By Type of Insulin:
By End User:
By Region:
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1.Introduction
1.1.Report Description
1.2.Research Methodology
1.2.1.Secondary Research
1.2.2.Primary Research
2.Executive Summary
2.1.Key Highlights
3.Market Overview
3.1.Introduction
3.1.1.Market Definition
3.1.2.Market Segmentation
3.2.Market Share Analysis
3.3.Market Dynamics
3.3.1.Drivers
3.3.1.1.Increasing Incidence of Diabetes Globally
3.3.1.2.Recent Technological Developments in Insulin Patch Pump
3.3.2.Restraints
3.3.2.1.Complexity of Insulin Patch Pump Systems
3.3.3.Opportunities
3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities
4.Insulin Patch Pump Market, By Type of Insulin
4.1.Introduction
4.2.Insulin Patch Pump Market Assessment and Forecast, By Type of Insulin, 2017-2027
4.3.Basal Insulin
4.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.Bolus Insulin
4.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5.Basal-bolus Insulin
4.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.Insulin Patch Pump Market, By End User
5.1.Introduction
5.2.Insulin Patch Pump Market Assessment and Forecast, By End User, 2017-2027
5.3.Hospitals
5.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4.Private Clinics
5.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5.Online Pharmacies
5.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.6.Retail Pharmacies
5.6.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.Insulin Patch Pump Market, By Region
6.1.Introduction
6.2.Insulin Patch Pump Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.3.North America
6.3.1.Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.3.2.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.3.3.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.1.U.S.
6.3.3.1.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.3.3.1.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.2.Canada
6.3.3.2.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.3.3.2.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.3.Mexico
6.3.3.3.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.3.3.3.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.Europe
6.4.1.Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.1.Germany
6.4.3.1.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.1.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.2.France
6.4.3.2.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.2.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.3.UK
6.4.3.3.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.3.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.4.Italy
6.4.3.4.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.4.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.5.Spain
6.4.3.5.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.5.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.6.Russia
6.4.3.6.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.6.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.7.Rest of Europe
6.4.3.7.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.4.3.7.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.Asia-Pacific
6.5.1.Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.1.Japan
6.5.3.1.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.1.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.2.China
6.5.3.2.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.2.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.3.Australia
6.5.3.3.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.3.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.4.India
6.5.3.4.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.4.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.5.South Korea
6.5.3.5.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.5.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.6.Taiwan
6.5.3.6.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.6.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.7.Rest of Asia-Pacific
6.5.3.7.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.5.3.7.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.Rest of the World
6.6.1.Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.1.Brazil
6.6.3.1.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.1.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.2.Turkey
6.6.3.2.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.2.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.3.Saudi Arabia
6.6.3.3.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.3.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.4.South Africa
6.6.3.4.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.4.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.5.United Arab Emirates
6.6.3.5.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.5.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.6.Others
6.6.3.6.1.Market Assessment and Forecast, By Type of Insulin, 2017-2027 ($Million)
6.6.3.6.2.Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.Company Profiles
7.1.Insulet Corporation
7.1.1.Business Overview
7.1.2.Product Portfolio
7.1.3.Key Financials
7.1.4.Strategic Developments
7.2.Valeritas Holdings, Inc.
7.2.1.Business Overview
7.2.2.Product Portfolio
7.2.3.Key Financials
7.2.4.Strategic Developments
7.3.Cellnovo Limited
7.3.1.Business Overview
7.3.2.Product Portfolio
7.3.3.Key Financials
7.3.4.Strategic Developments
7.4.CeQur SA
7.4.1.Business Overview
7.4.2.Product Portfolio
7.4.3.Strategic Developments
7.5.Becton, Dickinson and Company
7.5.1.Business Overview
7.5.2.Product Portfolio
7.5.3.Financials Available
7.5.4.Strategic Developments
7.6.Unilife Corporation
7.6.1.Business Overview
7.6.2.Product Portfolio
7.6.3.Key Financials
7.6.4.Strategic Developments
7.7.Debiotech S.A.
7.7.1.Business Overview
7.7.2.Product Portfolio
7.7.3.Strategic Developments
7.8.EOFLOW CO.,LTD
7.8.1.Business Overview
7.8.2.Product Portfolio
7.8.3.Strategic Developments
List of Tables
Table 1.Insulin Patch Pump Market, By Type of Insulin ($Million), 2017-2025
Table 2.Basal Insulin Market, By Region ($Million), 2017-2025
Table 3.Bolus Insulin Market, By Region ($Million), 2017-2025
Table 4.Basal-bolus Insulin Market, By Region ($Million), 2017-2025
Table 5.Insulin Patch Pump Market, By End User ($Million), 2017-2025
Table 6.Hospitals Market, By Region ($Million), 2017-2025
Table 7.Private Clinics Market, By Region ($Million), 2017-2025
Table 8.Online Pharmacies Market, By Region ($Million), 2017-2025
Table 9.Retail Pharmacies Market, By Region ($Million), 2017-2025
Table 11.Insulin Patch Pump Market, By Region ($Million), 2017-2025
Table12.North America Insulin Patch Pump Market, By Country, 2017-2025 ($Million)
Table13.North America Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 14.North America Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 15.U.S. Insulin Patch Pump Market, by Type of Insulin, 2017-2025 ($Million)
Table 16.U.S. Insulin Patch Pump Market, by End User, 2017-2025 ($Million)
Table 17.Canada Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 18.Canada Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 19.Mexico Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 20.Mexico Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 21.Europe Insulin Patch Pump Market, By Country, 2017-2025 ($Million)
Table 22.Europe Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 23.Europe Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 24.Germany Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 25.Germany Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 26.France Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 27.France Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 28.UK Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 29.UK Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 30.Italy Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 31.Italy Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 32.Spain Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 33.Spain Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 34.Russia Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 35.Russia Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 36.Rest of Europe Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 37.Rest of Europe Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 38.Asia-Pacific Insulin Patch Pump Market, By Country, 2017-2025 ($Million)
Table 39.Asia-Pacific Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 40.Asia-Pacific Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 41.Japan Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 42.Japan Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 43.China Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 44.China Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 45.Australia Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 46.Australia Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 47.India Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 48.India Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 49.South Korea Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 50.South Korea Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 51.Taiwan Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 52.Taiwan Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 53.Rest of Asia-Pacific Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 54.Rest of Asia-Pacific Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 55.Rest of the World Insulin Patch Pump Market, By Country, 2017-2025 ($Million)
Table 56.Rest of the World Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 57.Rest of the World Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 58.Brazil Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 59.Brazil Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 60.Turkey Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 61.Turkey Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 62.Saudi Arabia Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 63.Saudi Arabia Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 64.South Africa Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 65.South Africa Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 66.United Arab Emirates Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 67.United Arab Emirates Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 68.Others Insulin Patch Pump Market, By Type of Insulin, 2017-2025 ($Million)
Table 71.Others Insulin Patch Pump Market, By End User, 2017-2025 ($Million)
Table 72.Insulet Corporation: Key Strategic Developments, 2017-2017
Table 73.Valeritas Holdings, Inc.: Key Strategic Developments, 2017-2017
Table 74.Cellnovo Limited: Key Strategic Developments, 2017-2017
Table 75.CeQur SA: Key Strategic Developments, 2017-2017
Table 76.Becton, Dickinson and Company: Key Strategic Developments, 2017-2017
Table 77.Unilife Corporation: Key Strategic Developments, 2017-2017
Table 78.Debiotech S.A.: Key Strategic Developments, 2017-2017
Table 79.EOFLOW CO., LTD: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Insulin Patch Pump Market Share, By Type of Insulin, 2017 & 2025
Figure 2.Insulin Patch Pump Market, By End User, 2017, ($Million)
Figure 3.Insulin Patch Pump Market, By Region, 2017, ($Million)
Figure 4.Insulet Corporation: Net Revenues, 2017-2017 ($Million)
Figure 5.Insulet Corporation: Net Revenue Share, By Segment, 2017
Figure 6.Insulet Corporation: Net Revenue Share, By Geography, 2017
Figure 7.Valeritas Holdings, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 8.Valeritas Holdings, Inc.: Net Revenue Share, By Segment, 2017
Figure 9.Valeritas Holdings, Inc.: Net Revenue Share, By Geography, 2017
Figure 10.Cellnovo Limited: Net Revenues, 2017-2017 ($Million)
Figure 11.Cellnovo Limited: Net Revenue Share, By Segment, 2017
Figure 12.Cellnovo Limited: Net Revenue Share, By Geography, 2017
Figure 13.Becton, Dickinson and Company: Net Revenues, 2017-2017 ($Million)
Figure 14.Becton, Dickinson and Company: Net Revenue Share, By Segment, 2017
Figure 15.Becton, Dickinson and Company: Net Revenue Share, By Geography, 2017
Figure 16.Unilife Corporation: Net Revenues, 2017-2017 ($Million)
Figure 17.Unilife Corporation: Net Revenue Share, By Segment, 2017
Figure 18.Unilife Corporation: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|